Suppr超能文献

合并眼脉络膜和眼眶累及的 Erdheim-Chester 病:病例报告。

Erdheim-Chester disease with chorioretinal and orbital involvement: a case report.

机构信息

Ophthalmic Plastic & Reconstructive Surgery, University of Health Sciences Beyoglu Eye Training and Research Hospital, Istanbul, Turkey.

Ophthalmology Department, Memorial Hospital, Faculty of Medicine, Arel University.

出版信息

Arq Bras Oftalmol. 2023 Apr 3;87(5):e20220151. doi: 10.5935/0004-2749.2022-0151. eCollection 2023.

Abstract

A 42-year-old woman presented with bilateral proptosis, chemosis, leg pain, and vision loss. Orbital, chorioretinal, and multi-organ involvement of Erdheim-Chester disease, a rare non-Langerhans histiocytosis, with a negative BRAF mutation was diagnosed based on clinical, radiological, and pathological findings. Interferon-alpha-2a (IFNα-2a) was started, and her clinical condition improved. However, 4 months later, she had vision loss with a history of IFNα-2a cessation. The same therapy was administered, and her clinical condition improved. The Erdheim-Chester disease is a rare chronic histiocytic proliferative disease that requires a multidisciplinary approach and can be fatal if left untreated because of multisystemic involvements.

摘要

一位 42 岁女性因双侧眼球突出、球结膜水肿、腿部疼痛和视力丧失就诊。根据临床、影像学和病理学检查结果,诊断为 Erdheim-Chester 病(一种罕见的非朗格汉斯细胞组织细胞增生症),该疾病累及眼眶、脉络膜和多个器官,且 BRAF 突变阴性。给予干扰素-α-2a(IFNα-2a)治疗后,患者的临床状况有所改善。然而,4 个月后,患者因停止 IFNα-2a 治疗而出现视力丧失。再次给予相同的治疗后,患者的临床状况改善。Erdheim-Chester 病是一种罕见的慢性组织细胞增生性疾病,需要多学科治疗,如果不治疗,由于多系统受累,该病可能致命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7f6/11623916/720b90466091/abo-87-05-e2022-0151-g01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验